pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
409
stories
21d
Catheter Introducer Kit Recall: Abiomed Removes 14Fr Low Profile Introducer Kits
fda medwatch
21d
J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B
biopharma dive
21d
BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays
biospace
22d
Ebola outbreak nears milestone, while a vaccine remains months away
stat
22d
Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
fiercebiotech
22d
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
22d
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
biospace
22d
Is it safe to drink Red Bull and alcohol? Questionable research tied to energy drink giant has shaped policy
stat
22d
Capricor Duchenne cell therapy voted down by FDA panel
biopharma dive
22d
FDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute
fiercebiotech
22d
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
fda press
22d
Caldera, Vidya add to recent flurry of biotech mergers
biopharma dive
22d
AbCellera, Vertex partner on next-gen T-cell engagers
biopharma dive
22d
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
biopharma dive
22d
FDA reviewers criticize Replimune drug; ProMIS climbs on Alzheimer’s data
biopharma dive
23d
Incyte cuts early-stage cancer drug to focus on next-gen programs
biospace
23d
‘Low tech’ chemotherapy nanoparticles show promise for deadly brain tumor recurrence
fiercebiotech
23d
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
fiercebiotech
23d
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
23d
GSK prepares for patent cliff with $2.5B cost-cutting plan
biopharma dive
24d
Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options
fiercebiotech
24d
Altimmune’s next-gen GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 alcohol use disorder win
fiercebiotech
24d
Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
fiercebiotech
24d
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
stat
24d
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
stat
25d
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
stat
25d
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
25d
After missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration
fiercebiotech
25d
Opinion: How midwives like me can help fight medical misinformation
stat
25d
AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates
fiercebiotech
← prev
page 4 of 14
next →
